FDA Panel Backs Accelerated Approval for ALS Drug
In a momentous move, a group of experts from the FDA have given their seal of approval to expedite the approval process for Biogen Inc’s potential breakthrough treatment for ALS, a devastating neurological disease famously associated with baseball legend Lou Gehrig. The thrilling decision comes after an intensive review of compelling evidence that suggests the […]